Home GlaxoSmithKline (GSK)

GlaxoSmithKline (GSK)

GlaxoSmithKline (GSK) can trace its roots back to a small apothecary in 18th Century London. Through multiple corporate mergers, GSK found its current form in 2001. It manufactures prescription medicines, vaccines and consumer health products.

Last Modified: March 24, 2021
Fact Checked
Fact-Checked

Editors carefully fact-check all Drugwatch content for accuracy and quality.

Drugwatch has a stringent fact-checking process. It starts with our strict sourcing guidelines.

We only gather information from credible sources. This includes peer-reviewed medical journals, reputable media outlets, government reports, court records and interviews with qualified experts.

GlaxoSmithKline is a Big Pharma corporation. It sits at No. 282 on Forbes’ Global 500 rankings. GSK is ranked number 6 among the top 20 pharma companies by revenue in 2019, according to FiercePharma.

The British pharmaceutical company is well-known for products like Advair, Ventolin, Theraflu, Advil and Centrum.

Like many pharmaceutical companies, GSK has stepped up to develop treatments for COVID-19. In March 2021, the company announced an interim review of its experimental antibody VIR-7831, also known as GSK4182136, showed an 85 percent reduction in hospitalization or death, according to a company press release.

“We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer.”

But GSK has faced allegations of unethical and unsafe business practices. Some of its former employees were criminally prosecuted on two different continents.

Some of GSK’s popular pharmaceuticals have led to product liability lawsuits. These include Avandia, Zantac, Paxil, Prevacid 24HR, Nexium 24HR and Zofran.

About GlaxoSmithKline

GlaxoSmithKline is a global health care company with headquarters in Brentford, London. Emma Walmsley is GSK’s CEO. She is the first woman to be chief executive of a major pharmaceutical corporation.

fact
In 2020, GSK had 40 new medicines and 17 new vaccines in development.
Source: GSK Key Facts

Total revenues for GSK reached $34 billion pounds in 2020. This equates to $47.3 billion in U.S. currency.

In 2020, GSK employed about 94,000 people in over 150 countries. Its U.S. headquarters are in Philadelphia. GSK has a separate research facility in North Carolina.

GlaxoSmithKline History

GlaxoSmithKline started in 1715 as Plough Court pharmacy, a small apothecary shop in London. GSK evolved through a series of mergers over two centuries.

GSK Timeline
  • 1830
    Smith & Gilbert drug house opened in Philadelphia. (Mahlon Kline later joined the entity.)
  • 1842
    Thomas Beecham started Beecham’s Pills in England.
  • 1856
    Plough Court pharmacy took on the name Allen & Hanburys.
  • 1880
    American pharmacists Henry Wellcome and Silas Burroughs started Burroughs Wellcome & Company in London.
  • 1958
    Glaxo Laboratories acquired Allen & Hanburys.
  • 1989
    SmithKline Beckman and the Beecham Group merged to form SmithKline Beecham.
  • 1995
    Glaxo and Wellcome merged.
  • 2001
    SmithKline Beecham and Glaxo Wellcome merged in a $75.7 billion stock deal. This gave GlaxoSmithKline its official start.

GlaxoSmithKline Products

GSK focuses on vaccines, pharmaceutical drugs and consumer health care products. The company’s vaccine business distributes about 2 million vaccines a day to around 160 countries.

GSK is the maker of the industry’s broadest range of inhaled respiratory products. These include Advair, Ventolin and Breo Ellipta. The company has also partnered with Pfizer and Shionogi to form a global HIV business, ViiV Healthcare.

GSK’s respiratory and HIV pharmaceutical businesses are its top moneymakers. Overall, its pharmaceuticals business raked in about $24 billion (17 million pounds) in 2020.

Popular GSK Pharmaceuticals, Vaccines & Consumer Products
Prevacid 24HR and Nexium 24HR
Proton pump inhibitor heartburn and stomach acid reducers
Advair/Seretide
Inhaled asthma/COPD medication (combination steroid and bronchodilator)
Wellbutrin
Antidepressant
Avandia
Type 2 diabetes medicine
Flonase/Flovent
Inhaled corticosteroids
Zantac
Antihistamine that blocks stomach acid
Zofran
Anti-nausea medication
Theraflu
Cold and flu medicine
Nicorette
Gum and lozenges to aid in smoking cessation
Excedrin
Pain reliever for headaches and migraines
Abreva
Skin cream to treat cold sores or fever blisters
Fluarix/FluLava
Seasonal flu vaccines
Rotarix
Rotavirus vaccine
Ambirix
Hepatitis A and B vaccine
Bexsero
Meningitis B vaccine
Boostrix
Tetanus, diphtheria and pertussis vaccine
Menveo
Meningitis ACWY vaccine
Menjugate
Meningitis C vaccine
Priorix
Measles, mumps and rubella vaccine

GlaxoSmithKline Lawsuits and Settlements

GlaxoSmithKline has faced a number of product liability lawsuits. Patients filing lawsuits accuse the company of manufacturing dangerous or defective products.

Personal Injury Lawsuits Against GSK

Zantac

Injuries

Cancer from NDMA contamination

Lawsuit Status

GSK reported that it had been named in about 1,200 Zantac lawsuits on its 2020 annual report. In December 2020, the court granted GSK’s motion to dismiss claims on innovator liability. As of March 2021, there have been no verdicts or settlements.

Lawsuit Information
Individuals filing Zantac lawsuits claim GSK and other manufacturers knew about the dangers of NDMA in Zantac but failed to properly warn the public.
View Lawsuits

Zofran

Injuries

Birth defects

Lawsuit Status

GSK faced 476 federal Zofran lawsuits in February 2021. The first bellwether trial has been set for Oct. 18, 2021.

PPIs

Injuries

Acute kidney injury, chronic kidney disease and end-stage renal failure

Lawsuits Status

More than 13,700 PPI lawsuits are pending in federal court in New Jersey. GSK is named in thousands of claims for Prevacid 24HR and Nexium 24HR, the company said in its 2020 annual report. The first PPI bellwether is set for November 2021.

Learn About PPI Lawsuits

Paxil

Injuries

Suicidal thoughts and birth defects

Notable Verdicts

  • 2009
    Philadelphia jurors awarded $2.5 million in a Paxil lawsuit filed by the family of a 3-year-old born with severe heart malformations.
  • 2017
    Chicago jurors ordered GSK to pay $3 million to the widow of a corporate attorney who killed himself after taking a generic version of Paxil not made by GSK.

Notable Settlements

  • 2006
    GSK settled thousands of addiction claims for a total of $160 million.
  • 2010
    GSK settled Paxil and pregnancy claims for $1.14 billion.
  • 2016
    GSK paid $6.2 million to settle a Canada class action lawsuit involving 50 mothers and their children.

Avandia

Injuries

Strokes, heart attacks and heart failure

Notable Settlements

  • 2010
    GSK settled over 10,000 Avandia lawsuits for more than $500 million.
  • 2011
    GSK agreed to pay $250 million to settle 5,500 death and injury claims.
  • 2011
    GSK set aside $6.4 billion for future lawsuits and settlements.

Fraud, Misbranding & Failure to Report Safety Data

In 2012, GlaxoSmithKline pleaded guilty to federal criminal offenses. The company’s crimes included misbranding of its antidepressants Paxil and Wellbutrin. GSK also failed to report safety data to the FDA about its diabetes drug Avandia.

GSK admitted to illegally promoting Paxil for treatment of depression in children.

The company reached a civil settlement with the U.S. federal government in which it agreed to pay a fine of $3 billion.

The plea represented the largest health care fraud settlement in U.S. history. It resolved allegations of pricing fraud.

GSK reached a related civil settlement with the U.S. Justice Department. It resolved allegations of improper marketing of Advair and Zofran.

In March 2020, the Department of Justice (DOJ) sent GSK a notice of a civil investigation it had opened into allegations of False Claims Act violations by the company because of Zantac. DOJ requested documents on June 18, 2020. On the same day, the New Mexico Attorney General filed a lawsuit against GSK for violations of false advertising statutes and state consumer protection, among other claims.

GlaxoSmithKline Drug Recalls

GlaxoSmithKline recalled some of its products for defects, possible tampering and reduced effectiveness. Products affected include consumer weight loss products, vaccines and albuterol inhalers.

Recent GSK recalls
DateDrug/Device/VaccineUnitsReason
2020Children's Robitussin Honey Cough and Chest Congestion DM and Children's Dimetapp Cold and CoughLots: 02177 (Exp. Jan. 2022), 02178 (Exp. Jan. 2022) and CL8292 (Exp. Sep. 2021)Inclusion of incorrect dosing cups that could lead to accidental overdose
2018Ventolin and Seretide200,000Possible damaged foil strip containing medication inside the device resulting in reduced number of doses delivered by the inhaler
2017Ventolin600,000Leak in the propellant that delivers the medicine resulting in a smaller dose of medication than indicated
2017Menveo Meningococcal vaccineLot M16095 only (5 doses – 10 vials – per package)Precautionary; the batch was subject to mechanical intervention during sanitary filling operations not supported by validation data
2015Flulaval Quadrivalent Thimerosal-free Pre-Filled Syringes (PFS) flu vaccineAll remaining 2014-2015 dosesPotential for reduced effectiveness due to a decrease in vaccine strength prior to its expiration date found through routine testing
2015Ventolin HFAMore than 128,000Defective delivery system resulting in less than 200 doses
2014Alli weight loss productsFrom all U.S. and Puerto Rico retailersSome of the packages were tampered with and may contain product that is not alli

GlaxoSmithKline Scandal

A Chinese court ordered GlaxoSmithKline to pay $492 million in 2014. The fine resolved charges of bribing doctors in China to use GSK products. It was the biggest penalty ever imposed by a Chinese court.

The court sentenced Briton Mark Reilly to four years in prison. He was the company’s British executive for China. Four other Chinese employees received the same punishment.

But the employees may never serve prison time. The court postponed the sentences. Reilly was deported.

In February 2018, GSK was still answering to fraud investigators in its home country.

Please seek the advice of a medical professional before making health care decisions.